Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
33 pending office actions • 12 art units • 27 examiners • 0 of 33 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days
Intervet Inc. has 34 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 28 distinct examiners and 13 distinct art units. This indicates a broad distribution of the portfolio, though some examiners are handling multiple cases. JEFFREY MARK SIFFORD is the busiest examiner, with 3 pending office actions.
The 13 distinct art units involved suggest that the company's biotechnology and pharmaceutical filings cover a wide range of specialized technical classifications. Managing 34 pending actions across 28 distinct examiners requires coordinating with a large number of individual patent office officials. The presence of 13 distinct art units indicates that the company's research and development efforts are being evaluated by many different specialized groups. This decentralized prosecution landscape, involving 28 distinct examiners, suggests that the company's patent outcomes are subject to a wide variety of individual examiner perspectives.
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (3%) |
| §103 only | 8 (24%) |
| §112 only | 3 (9%) |
| Double-patenting only | 1 (3%) |
| Double-patenting + other | 8 (24%) |
| Multi-statute (no §101) | 12 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SIFFORD, JEFFREY MARK | 3 | 55.1% | +32.8% |
| ZEMAN, ROBERT A | 2 | 54.3% | +27.7% |
| CHESTNUT, BARRY A | 2 | 73.5% | +6.4% |
| BOESEN, AGNIESZKA | 2 | 68.5% | +21.8% |
| DICKENS, AMELIA NICOLE | 2 | 47.6% | +21.1% |
| GANGLE, BRIAN J | 1 | 76.7% | +14.7% |
| SHIM, DAVID M. | 1 | 58.3% | +58.3% |
| MCINTOSH III, TRAVISS C | 1 | 73.2% | +14.0% |
| SALVOZA, M FRANCO G | 1 | 68.4% | +30.0% |
| MAHADEVAN, JANAKI ANANTH | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18290819 | SYSTEM AND METHOD FOR PREDICTING ILLNESS, DEATH AND/OR OTHER ABNORMAL CONDITION OF AN ANIMAL | WINAKUR, ERIC FRANK | 31d overdue |
| 18257600 | CONJUGATED AFLATOXIN B TO PROTECT AGAINST MYCOTOXICOSIS | KIM, YUNSOO | 15d overdue |
| 18335415 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | BORALSKY, LUKE ALAN | 9d overdue |
| 18257420 | CONJUGATED T-2 TOXIN TO PROTECT AGAINST MYCOTOXICOSIS | MORGAN, BAILEY MICHELLE | 8d overdue |
| 18263211 | ANTIPARASITIC COMPOUNDS | SZNAIDMAN, MARCOS L | 9d |
| 18873753 | VACCINE FOR PROTECTION AGAINST LEPTOSPIRA SEROVAR ICTEROHAEMORRHAGIAE | ZEMAN, ROBERT A | — |
| 18721947 | AN INJECTABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES IN ANIMALS | SHIM, DAVID M. | — |
| 18294592 | METHOD OF TREATING VETERINARY VIRAL DISEASES | MAHADEVAN, JANAKI ANANTH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17641031 | COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION | ZEMAN, ROBERT A | 34d |
| 19094116 | CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSIS | GANGLE, BRIAN J | — |
| 18873753 | VACCINE FOR PROTECTION AGAINST LEPTOSPIRA SEROVAR ICTEROHAEMORRHAGIAE | ZEMAN, ROBERT A | — |
| 18723259 | STABILISED LIQUID VACCINES OF LIVE VIRUSES | BOESEN, AGNIESZKA | — |
| 18721947 | AN INJECTABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES IN ANIMALS | SHIM, DAVID M. | — |
| 18720093 | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTIC INFECTIONS | MCINTOSH III, TRAVISS C | — |
| 18643377 | RABIES VIRUS VACCINE | SALVOZA, M FRANCO G | — |
| 18702577 | A VACCINE FOR THE PROTECTION OF PIGLETS AGAINST SWINE INFLUENZA A VIRUS INFECTION | BOESEN, AGNIESZKA | — |
| Art Unit | Apps |
|---|---|
| 1645 | 5 |
| 1671 | 4 |
| 1641 | 4 |
| 1629 | 2 |
| 3791 | 1 |
| 1628 | 1 |
| 1624 | 1 |
| 1622 | 1 |
| 1672 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19094116 | CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSIS | GANGLE, BRIAN J | — | §102§103DP | Non-Final OA | — | Pending | Mar 28, 2025 |
| 18873753 | VACCINE FOR PROTECTION AGAINST LEPTOSPIRA SEROVAR ICTEROHAEMORRHAGIAE | ZEMAN, ROBERT A | — | §102§112 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18794860 | FELINE LEUKEMIA VIRUS VACCINE | CHESTNUT, BARRY A | — | DP | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18723259 | STABILISED LIQUID VACCINES OF LIVE VIRUSES | BOESEN, AGNIESZKA | — | §103 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18721947 | AN INJECTABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES IN ANIMALS | SHIM, DAVID M. | — | §102§103§112Other | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18720093 | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTIC INFECTIONS | MCINTOSH III, TRAVISS C | — | §103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18643377 | RABIES VIRUS VACCINE | SALVOZA, M FRANCO G | — | §103DP | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18702577 | A VACCINE FOR THE PROTECTION OF PIGLETS AGAINST SWINE INFLUENZA A VIRUS INFECTION | BOESEN, AGNIESZKA | — | §102§103§112DP | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18683835 | METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE | CHESTNUT, BARRY A | — | §102§103DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18684161 | METHOD OF PRODUCING A FOOT AND MOUTH DISEASE VIRUS VIRUS-LIKE PARTICLE | SIFFORD, JEFFREY MARK | 1671 | §103DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18294592 | METHOD OF TREATING VETERINARY VIRAL DISEASES | MAHADEVAN, JANAKI ANANTH | — | §102§103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18293007 | A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES | DUFFY, PATRICIA ANN | 1645 | §112Other | Final Rejection | 8d overdue | Pending | Jan 29, 2024 |
| 18290819 | SYSTEM AND METHOD FOR PREDICTING ILLNESS, DEATH AND/OR OTHER ABNORMAL CONDITION OF AN ANIMAL | WINAKUR, ERIC FRANK | 3791 | §101§102§103§112 | Final Rejection | 31d overdue | Pending | Jan 22, 2024 |
| 18416336 | ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS | TRAN, ERIC | 1629 | §103 | Non-Final OA | 41d | Pending | Jan 18, 2024 |
| 18570077 | A SYSTEM AND METHOD FOR MONITORING THE EFFECT OF A HERPESVIRUS-BASED VACCINE IN AN ANIMAL POPULATION | SIFFORD, JEFFREY MARK | 1671 | §103§112 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18570326 | PALATABLE VETERINARY COMPOSITIONS | SEITZ, ANTHONY JOSEPH | 1629 | §102§103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18264446 | VACCINATION FOR PROTECTING POULTRY AGAINST A POULTRY PATHOGEN | LY, KRISTINA ELISABETH | 1641 | §102§103§112DP | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18263211 | ANTIPARASITIC COMPOUNDS | SZNAIDMAN, MARCOS L | 1628 | §102§103 | Final Rejection | 9d | Pending | Jul 27, 2023 |
| 18257600 | CONJUGATED AFLATOXIN B TO PROTECT AGAINST MYCOTOXICOSIS | KIM, YUNSOO | 1641 | §102§103 | Final Rejection | 15d overdue | Pending | Jun 15, 2023 |
| 18335415 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | BORALSKY, LUKE ALAN | 1624 | §102§112 | Non-Final OA | 9d overdue | Pending | Jun 15, 2023 |
| 18257409 | CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS | TAYLOR, LIA ELAN | 1641 | §103 | Non-Final OA | 23d overdue | Pending | Jun 14, 2023 |
| 18257420 | CONJUGATED T-2 TOXIN TO PROTECT AGAINST MYCOTOXICOSIS | MORGAN, BAILEY MICHELLE | 1645 | §103§112 | Final Rejection | 8d overdue | Pending | Jun 14, 2023 |
| 18253140 | METHOD OF TREATMENT OF PAIN THROUGH BUCCAL ADMINISTRATION OF FLUNIXIN | SOROUSH, LAYLA | 1622 | §103 | Final Rejection | — | Pending | May 16, 2023 |
| 18252624 | RECOMBINANT VECTORS ENCODING CHIMERIC CORONAVIRUS SPIKE PROTEINS AND USE THEREOF | SIFFORD, JEFFREY MARK | 1671 | §103§112 | Non-Final OA | — | Pending | May 11, 2023 |
| 18250106 | COMBINATION VACCINE FOR PROTECTING SWINE AGAINST VARIOUS DISORDERS | SZPERKA, MICHAEL EDWARD | 1641 | §103Other | Final Rejection | 34d | Pending | Apr 21, 2023 |
| 18249419 | BACULOVIRUS EXPRESSION VECTOR | JADHAO, SAMADHAN JAISING | 1672 | §103 | Final Rejection | 5d overdue | Pending | Apr 18, 2023 |
| 17819745 | PD-L1 ANTIBODIES BINDING CANINE PD-L1 | DUFFY, BRADLEY | 1643 | §112 | Non-Final OA | 12d | Pending | Aug 15, 2022 |
| 17785223 | REASSORTED ISA VIRUS | ALLEN, MICHAEL D | 1671 | §112DP | Final Rejection | — | Pending | Jun 14, 2022 |
| 17783220 | PARASITE CONTROL IN RUMINANTS | MCMILLIAN, KARA RENITA | 1623 | §103 | Final Rejection | 38d overdue | Pending | Jun 07, 2022 |
| 17775425 | A NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS | DICKENS, AMELIA NICOLE | 1645 | §102§112 | Non-Final OA | — | Pending | May 09, 2022 |
| 17775428 | NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS | DICKENS, AMELIA NICOLE | 1645 | §102§112 | Non-Final OA | — | Pending | May 09, 2022 |
| 17641031 | COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION | ZEMAN, ROBERT A | 1645 | §112 | Final Rejection | 34d | Pending | Mar 07, 2022 |
| 16761670 | INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION | SAEED, ALI S | 1616 | §103DP | Non-Final OA | — | Pending | May 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial